Summary of Department
We make an accurate diagnosis as quickly as possible with various endoscopes and sonographic devices and offer the latest and best treatment options for hepato-biliary-pancreatic diseases, including malignancy. We consistently perform early diagnoses, medical treatment and palliative treatment for cancer, so patients with such diseases are first assessed in our department. We ensure that we apply the best treatment policies through multidisciplinary treatment, with decisions made by a cancer board consisting of physicians, surgeons, radiologists and pathologists. Cutting-edge technology in the field of gastroenterology, like stent placement for biliary or duodenal obstruction, endoscopic esophageal varices treatment and cell-free and concentrated ascites reinfusion therapy have helped us to relieve patients’ symptoms in palliative care. We also administer novel anticancer drugs and molecular-targeted drugs for unresectable advanced hepatic, pancreatic and biliary cancer, and we believe that the best management for any patient with cancer is in a clinical trial. Participation in clinical trials is particularly strongly encouraged in our department, and several clinical trials are ongoing at present, with the number of trials based on cancer genome medicine increasing in recent years. We also perform tissue MSI tests and liquid biopsies.